Radius Completes Enrollment of Phase II Clinical Trial of BA058 for Osteoporosis (PR Newswire via Yahoo! Finance)
Radius Health announced today the completion of patient enrollment into its Phase II clinical trial of BA058, the company’s bone anabolic candidate for treatment of osteoporosis. The Phase II dose-finding study is designed to further evaluate the ability of BA058 to build new bone for the treatment of osteoporosis in postmenopausal women.